Status:
COMPLETED
GraviD-child Follow-up of the Children´s Health, Growth and Development Within the GraviD-study
Lead Sponsor:
Göteborg University
Collaborating Sponsors:
Sahlgrenska University Hospital
Norwegian Institute of Public Health
Conditions:
Vitamin D Deficiency
Body Composition
Eligibility:
All Genders
7-9 years
Brief Summary
GraviD is a multi-ethnic population-based pregnancy cohort. Pregnant women were invited to participate in the GraviD study when registering for antenatal care in parts of the region of Västra Götaland...
Detailed Description
In the GraviD-child study, all healthy singleton children born within the GraviD study will be invited to participate in a single clinical follow up. The follow-up will be conducted when all children ...
Eligibility Criteria
Inclusion
- Born within the GraviD study
- Healthy
- Singleton
Exclusion
- Chromosomal abnormality
- Hyper-/Hypothyroidism
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 14 2023
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT05228925
Start Date
February 1 2022
End Date
February 14 2023
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Silvia Children's Hospital
Gothenburg, Sweden, 41650